MDWD
MediWound Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$14.12
+5.45%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$13.05
From 52W high−27.10%
Volume173763.00
Market cap$182.29M
P/E (TTM)—
P/S (TTM)15.4x
Div yield—
Key dataNov 4, 2026
Open
$13.05
From 52W high
−27.10%
Volume
173763.00
Market cap
$182.29M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−8.2x
P/E (TTM)
—
RSI (14)
60.4
MomentumView details →
1D Return
+5.45%
YTD Return
−24.88%
SummaryUpdated Jun 1, 2026
MediWound Ltd. (NASDAQ:MDWD) is an Israeli biopharmaceutical company founded in 2000 and headquartered in Yavne, Israel. The company went public on NASDAQ in March 2014. MediWound specializes in developing, manufacturing, and commercializing novel enzymatic bio-therapeutic solutions for tissue repair and regeneration, with a primary focus on wound debridement - the medical process of removing dead, damaged, or infected tissue to promote healing.
Similar companies
Latest newsMore news →
MediWound announced that it entered into an underwriting agreement for a $15 million bought deal offering of ordinary shares.22h agoMediWound announced that it will report its third-quarter 2026 financial results and hold a conference call and webcast on November 12, 2026, at 8:30 a.m. Eastern Time.6d ago